Tactile Systems Technology, Inc. (TCMD)
| Previous close | 10.06 |
| Open | 9.99 |
| Bid | 10.26 x 800 |
| Ask | 10.28 x 1000 |
| Day's range | 9.84 - 10.34 |
| 52-week range | 6.28 - 46.41 |
| Volume | |
| Avg. volume | 502,475 |
| Market cap | 208.146M |
| Beta (5Y monthly) | 1.49 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.27 |
| Earnings date | 07 Nov 2022 - 11 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 23.33 |
- Zacks
Tactile Systems Technology (TCMD) Reports Q2 Loss, Tops Revenue Estimates
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 12.50% and 4.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Tactile Systems Technology, Inc. Reports Second Quarter 2022 Financial Results; Raises Full Year 2022 Outlook
Second Quarter Revenue Increased 17% Year-Over-Year; First Half Revenue Increased 15% Year-Over-YearMINNEAPOLIS, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the second quarter and six months ended June 30, 2022. Second Quarter 2022 Summary: Total revenue increased
- GlobeNewswire
Tactile Medical Introduces New ComfortEase™ Flexitouch® Plus Garments and Kylee™ Mobile Application
Flexitouch Plus garments redesigned to improve the patient experience; the Kylee app empowers patients through digital health monitoringMINNEAPOLIS, July 25, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, announced today the full market release of its new ComfortEase™ garments, part of the Flexitouch® Plus syste
